Cargando…

Lack of effect of sublingual salvinorin A, a naturally occurring kappa opioid, in humans: a placebo-controlled trial

RATIONALE: Salvinorin A (SA) is a highly selective kappa opioid receptor agonist and the putative psychoactive compound in Salvia divinorum (SD), an increasingly abused hallucinogenic plant. OBJECTIVES: The objectives of this study were to characterize the physiological and subjective effects of SA...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mendelson, John E., Coyle, Jeremy R., Lopez, Juan Carlos, Baggott, Matthew J., Flower, Keith, Everhart, E. Thomas, Munro, Thomas A., Galloway, Gantt P., Cohen, Bruce M.
Formato:	Texto
Lenguaje:	English
Publicado:	Springer-Verlag 2010
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3063546/ https://www.ncbi.nlm.nih.gov/pubmed/21140258 http://dx.doi.org/10.1007/s00213-010-2103-5

Ejemplares similares

Kappa Opioids, Salvinorin A and Major Depressive Disorder
por: Taylor, George T., et al.
Publicado: (2016)

Developing Biomarkers for Methamphetamine Addiction
por: Mendelson, John, et al.
Publicado: (2011)

The Kappa Opioid Receptor and the Sleep of Reason: Cortico-Subcortical Imbalance Following Salvinorin-A
por: Ona, Genís, et al.
Publicado: (2021)

Solving an Old Puzzle: Elucidation and Evaluation of the Binding Mode of Salvinorin A at the Kappa Opioid Receptor
por: Puls, Kristina, et al.
Publicado: (2023)

8-epi-Salvinorin B: crystal structure and affinity at the κ opioid receptor
por: Munro, Thomas A, et al.
Publicado: (2007)

Salvinorin B methoxymethyl ether
por: Munro, Thomas A., et al.
Publicado: (2012)

Studies toward bivalent κ opioids derived from salvinorin A: heteromethylation of the furan ring reduces affinity
por: Munro, Thomas A, et al.
Publicado: (2013)

Imagery Scripts and a Computerized Subtraction Stress Task Both Induce Stress in Methamphetamine Users: A Controlled Laboratory Study
por: Garrison, Kathleen J., et al.
Publicado: (2010)

Synthesis and κ-Opioid Receptor Activity of Furan-Substituted Salvinorin A Analogues
por: Riley, Andrew P., et al.
Publicado: (2014)

Salvinorin A Administration after Global Cerebral Hypoxia/Ischemia Preserves Cerebrovascular Autoregulation via Kappa Opioid Receptor in Piglets
por: Wang, Zhenhong, et al.
Publicado: (2012)

Salvinorin A, a kappa-opioid receptor agonist hallucinogen: pharmacology and potential template for novel pharmacotherapeutic agents in neuropsychiatric disorders
por: Butelman, Eduardo R., et al.
Publicado: (2015)

Kappa Opioid Receptor Agonist Mesyl Sal B Attenuates Behavioral Sensitization to Cocaine with Fewer Aversive Side-Effects than Salvinorin A in Rodents
por: Kivell, Bronwyn M., et al.
Publicado: (2018)

Investigating the Mechanisms of Hallucinogen-Induced Visions Using 3,4-Methylenedioxyamphetamine (MDA): A Randomized Controlled Trial in Humans
por: Baggott, Matthew J., et al.
Publicado: (2010)

Corrigendum: Salvinorin A, a kappa-opioid receptor agonist hallucinogen: pharmacology and potential template for novel pharmacotherapeutic agents in neuropsychiatric disorders
por: Butelman, Eduardo R., et al.
Publicado: (2015)

The Salvinorin Analogue, Ethoxymethyl Ether Salvinorin B, Promotes Remyelination in Preclinical Models of Multiple Sclerosis
por: Paton, Kelly F., et al.
Publicado: (2021)

MDMA Impairs Response to Water Intake in Healthy Volunteers
por: Baggott, Matthew J., et al.
Publicado: (2016)

The Kappa Opioid Receptor Agonist 16-Bromo Salvinorin A Has Anti-Cocaine Effects without Significant Effects on Locomotion, Food Reward, Learning and Memory, or Anxiety and Depressive-like Behaviors
por: van de Wetering, Ross, et al.
Publicado: (2023)

Formal Total Synthesis of Salvinorin A
por: Halang, Marc, et al.
Publicado: (2022)

Studies toward the Development of Antiproliferative Neoclerodanes from Salvinorin A
por: Vasiljevik, Tamara, et al.
Publicado: (2014)

Cutting-Edge Search for Safer Opioid Pain Relief: Retrospective Review of Salvinorin A and Its Analogs
por: Zjawiony, Jordan K., et al.
Publicado: (2019)

Evaluation of Biased and Balanced Salvinorin A Analogs in Preclinical Models of Pain
por: Paton, Kelly F., et al.
Publicado: (2020)

Therapeutic Potential of Kappa Opioid Agonists
por: Beck, Tyler C., et al.
Publicado: (2019)

Unusual hemiacetal structure derived from Salvinorin A
por: Carvalho, Paulo, et al.
Publicado: (2008)

Salvinorin A Does Not Affect Seizure Threshold in Mice
por: Socała, Katarzyna, et al.
Publicado: (2020)

A Protecting‐Group‐Free Synthesis of (−)‐Salvinorin A
por: Zimdars, Patrick, et al.
Publicado: (2021)

The Acute Effects of the Atypical Dissociative Hallucinogen Salvinorin A on Functional Connectivity in the Human Brain
por: Doss, Manoj K., et al.
Publicado: (2020)

Salvinorin A Inhibits Airway Hyperreactivity Induced by Ovalbumin Sensitization
por: Rossi, Antonietta, et al.
Publicado: (2017)

A Route to Potent, Selective, and Biased Salvinorin Chemical Space
por: Hill, Sarah J., et al.
Publicado: (2023)

Feasibility of Ecological Momentary Assessment Using Cellular Telephones in Methamphetamine Dependent Subjects
por: Galloway, Gantt P, et al.
Publicado: (2008)

Pharmacological profiles of opioid ligands at Kappa opioid receptors
por: Gharagozlou, Parham, et al.
Publicado: (2006)

Agonist-Promoted Phosphorylation and Internalization of the Kappa Opioid Receptor in Mouse Brains: Lack of Connection With Conditioned Place Aversion
por: Chen, Chongguang, et al.
Publicado: (2022)

Pharmacokinetics and Pharmacodynamics of Salvinorin A and Salvia divinorum: Clinical and Forensic Aspects
por: Brito-da-Costa, Andreia Machado, et al.
Publicado: (2021)

Therapeutic Potential of Salvinorin A and Its Analogues in Various Neurological Disorders
por: Cichon, Joseph, et al.
Publicado: (2022)

Salvaging Salvinorin: From Hallucinogen to Potential Therapeutic through Chemical Synthesis
por: Duvvuru, Bhawyanth, et al.
Publicado: (2023)

Role of kappa‐opioid and mu‐opioid receptors in pruritus: Peripheral and central itch circuits
por: Kim, Brian S., et al.
Publicado: (2022)

Repeated Administration of Norbinaltorphimine Produces Cumulative Kappa Opioid Receptor Inactivation
por: Chavkin, Charles, et al.
Publicado: (2019)

Naltrexone but Not Ketanserin Antagonizes the Subjective, Cardiovascular, and Neuroendocrine Effects of Salvinorin-A in Humans
por: Maqueda, Ana Elda, et al.
Publicado: (2016)

A (–)-kolavenyl diphosphate synthase catalyzes the first step of salvinorin A biosynthesis in Salvia divinorum
por: Chen, Xiaoyue, et al.
Publicado: (2017)

Rapid Detection and Quantification of Hallucinogenic Salvinorin A in Commercial Salvia divinorum Products by DART-HRMS
por: Chambers, Megan I., et al.
Publicado: (2022)

Kappa opioid receptor antagonism: Are opioids the answer for treatment resistant depression?
por: Peckham, Alyssa M., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_kdrvotk5vub97dbp4o23s3te0n